|
Code
|
4508D
|
|
MA number
|
59/0114/20-S
|
|
Product Form:
|
sus iru 5x0,7 ml (striek.inj.skl.napl. s ihlou)
|
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
|
Type of procedure:
|
Decentralised
|
|
MAH, country:
|
Sanofi Winthrop Industrie, France
|
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J07 |
VACCINES |
| J07B |
VIRAL VACCINES |
| J07BB |
Influenza vaccines |
| J07BB02 |
Influenza, inactivated, split virus or surface antigen |
|
|
Shelf life:
|
12 |
|
Route of admin.:
|
Intramuscular and subcutaneous use
|
SPC_Efluelda Tetra_01.2025.pdf
